Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA

Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA

Dr. Alexandros Marios Sofias, RWTH Aachen University, Germany

This webinar describes a multiscale and multimodal optical imaging approach for evaluating core-crosslinked polymeric micelles (CCPM) designed for cancer treatment. The biodistribution and target site accumulation of CCPM were macroscopically and microscopically investigated. To this end, fluorophore-labeled CCPM were intravenously injected in mice bearing 4T1 triple-negative breast cancer (TNBC) tumors, and their localization at the whole-body, tissue and cellular level was analyzed using multimodal and multiscale optical imaging. At the organism level, a non-invasive 3D micro-computed tomography-fluorescence tomography (μCT-FLT) and 2D fluorescence reflectance imaging (FRI) was performed. At the tissue and cellular level, extensive immunohistochemistry, focusing primarily on cancer, endothelial and phagocytic immune cells was performed.

Took place: November, 2020


You may also like

Bart Cornelissen imaging DNA damage webinar thumbnail
Each DNA damage repair pathway leads to the recruitment, upregulation, or activation of specific proteins within the nucleus, which, in some cases, can represent attractive targets for molecular imaging.
Fabian Kiessling webinar thumbnail
For a detailed biodistribution analysis, PET and SPECT are usually preferred as they are more accurate and quantitative, so the question is, can optical imaging become a complementary tool for pre-clinical biodistribution analysis.
webinar thumnail Marko Rosenholm
Marko Rosenholm presents some of the findings and results regarding dynamic SPECT/CT imaging of a glymphatic system they have acquired with the MILabs VECTor/CT system.
Scroll to Top